With a large number of people relying on supplements to reduce their osteoarthritis pain, our researchers at the Kolling Institute have conducted a much-needed review of the most popular ones. The condition is impacting an increasing number of people, with many experiencing joint pain and functional impairment due to the disabling disease. Sadly, there is a lack of effective drugs to treat the cond.....
Read more

The latest Kolling Institute NEWS is out ... providing a snapshot of the wonderful research activity across our institute from our work into heart disease, pain, diabetes, cancer and musculoskeletal conditions. Check it out.
Read more

A valuable digital resource has been launched to help people with spinal cord injuries troubleshoot some of the complex health challenges that can arise after injury. The Spinal Cord Injury Health Maintenance Tool, which includes a website, smartphone app and hardcopy booklets, has been designed to empower people to self-manage their health-related needs and maintain a high quality of life. Launche.....
Read more

Our researchers at the Kolling Institute are set to influence the delivery of osteoarthritis care across Australia following a significant funding announcement. More than $1.4 million has been awarded to internationally recognised rheumatologist and researcher Professor David Hunter as part of the NHMRC Partnership Project Grants Scheme. The scheme is designed to help researchers work directly with.....
Read more

We would like to congratulate Kolling Institute researcher Amanda Purcell who has received a Juvenile Diabetes Research Foundation scholarship. Amanda is part of our Renal Research Laboratory, working to improve treatment for those with diabetes and kidney disease. She has been awarded a top-up scholarship aimed at supporting PhD students pursuing type 1 diabetes research in line with the foundatio.....
Read more

With a concerning rise in the number of people developing Type 2 diabetes, our researchers at the Kolling Institute are offering hope and an effective way forward to reduce the impact of the serious disease. Type 2 diabetes is the fastest growing chronic disease in the world, and if the current trend continues, it’s anticipated close to three million Australians will have the disease by 2025. It of.....
Read more

The Kolling Institute hosted a special visit by the family of the late Bill Walsh who donated vital funds to establish a cancer laboratory within the Kolling. His family, including his wife, daughters and grandchildren visited the lab to maintain their strong ties with the research team and meet with Academic Director Professor Jim Elliott. Established in 1980, the Bill Walsh Cancer Research Labora.....
Read more

With the number of people living with low back pain escalating sharply, researchers are turning to widely-accessible technology to reduce the impact of the disabling condition. The team from the University of Sydney and the Kolling Institute has launched a study measuring the effectiveness of a mobile health program which offers self-management strategies via text messages. Study lead Professor Man.....
Read more

The expertise across Australia’s space medicine community was showcased during a special event co-ordinated by the Kolling Institute and the Australasian Society of Aerospace Medicine. Staged over two days, the colloquium involved national and international experts including representatives from the Australian Space Agency, the CSIRO, Boeing and the Australian Antarctic Program. Presenters discusse.....
Read more

Researchers at the Kolling Institute have made important progress towards the development of new treatments for chronic pain by identifying a small group of cells which can control pain responses. The breakthrough comes as approximately 20 per cent of the world’s population suffers from chronic pain, including around 3.4 million Australians. Dr Neda Assareh, a neuroscientist research fellow from th.....
Read more